<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Volatility on FinanClub</title>
    <link>https://finan.club/tags/volatility/</link>
    <description>Recent content in Volatility on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 03 Apr 2024 09:02:59 +0000</lastBuildDate><atom:link href="https://finan.club/tags/volatility/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>ETRN</title>
      <link>https://finan.club/us/etrn/</link>
      <pubDate>Wed, 03 Apr 2024 09:02:59 +0000</pubDate>
      
      <guid>https://finan.club/us/etrn/</guid>
      <description>score:-10
Chances: EQT&amp;rsquo;s acquisition of Equitrans Midstream for $5.5 billion unveils the CEO&amp;rsquo;s vision for AI-driven growth. Risks: NextEra Energy Partners&amp;rsquo; unit price has fallen dramatically, indicating potential volatility in the energy sector. Score:-10 chances characters count - risks characters count = -10</description>
    </item>
    
    <item>
      <title>BTG</title>
      <link>https://finan.club/us/btg/</link>
      <pubDate>Mon, 11 Mar 2024 09:08:12 +0000</pubDate>
      
      <guid>https://finan.club/us/btg/</guid>
      <description>score:47
Chances: North American gold mining companies remain sound choices for investors Oversold stocks can be an opportunity for shrewd investors B2Gold reports consolidated gold production of 2,70,611 ounces in the fourth quarter of 2023 Risks: Mines can get played out and expected deposits may fail to materialize The price of gold can be volatile B2Gold Corp.</description>
    </item>
    
    <item>
      <title>PDD</title>
      <link>https://finan.club/us/pdd/</link>
      <pubDate>Tue, 27 Feb 2024 09:07:21 +0000</pubDate>
      
      <guid>https://finan.club/us/pdd/</guid>
      <description>score:-28
Chances: The Chinese online marketplace is taking the U.S. by storm as Etsy and Wayfair are already struggling to expand their audience. This high-growth Chinese e-commerce company still has plenty of room to grow. Among the blue-chip stocks, certain tech giants stand on the brink of a monumental surge.</description>
    </item>
    
    <item>
      <title>PLUG</title>
      <link>https://finan.club/us/plug/</link>
      <pubDate>Tue, 20 Feb 2024 09:06:18 +0000</pubDate>
      
      <guid>https://finan.club/us/plug/</guid>
      <description>score:160
Chances: Plug Power Inc. announced a comprehensive initiative to significantly reduce its annual operational expenses by more than $75 million, which could enhance its financial performance and ensure long-term value creation in a competitive market. The company delivered first-of-its-kind portable refuelers to transit agencies and trucking fleet customers, removing a significant barrier to the consideration of fuel cell electric vehicles.</description>
    </item>
    
    <item>
      <title>OWL</title>
      <link>https://finan.club/us/owl/</link>
      <pubDate>Thu, 18 Jan 2024 09:06:03 +0000</pubDate>
      
      <guid>https://finan.club/us/owl/</guid>
      <description>score:46
Chances: Blue Owl Capital Inc. and Blue Owl Capital Corporation are both scheduled to release their financial results for the fourth quarter, providing potential opportunities for investors to assess the performance of these companies. Risks: The volatility of the stock market and potential fluctuations in the financial performance of Blue Owl Capital Inc.</description>
    </item>
    
    <item>
      <title>MRNA</title>
      <link>https://finan.club/us/mrna/</link>
      <pubDate>Wed, 17 Jan 2024 09:04:41 +0000</pubDate>
      
      <guid>https://finan.club/us/mrna/</guid>
      <description>score:-55
Chances: Moderna&amp;rsquo;s product pipeline includes a wide range of modalities, such as prophylactic vaccines, cancer vaccines, and localized regenerative therapeutics, providing opportunities for significant future growth. The company&amp;rsquo;s focus on intratumoral immuno-oncology and systemic intracellular therapeutics reflects a strong commitment to addressing complex medical challenges with innovative solutions.</description>
    </item>
    
  </channel>
</rss>
